Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Adjunctive homeopathic treatment of hospitalized COVID-19 patients (COVIHOM): A retrospective case series (2021) |
Auteurs : | Michael Takacs ; Michael Frass ; Gernot Walder ; et al. |
Type de document : | Article |
Dans : | Complementary Therapies in Clinical Practice (Vol. 44, August 2021) |
Article en page(s) : | p. 1-11 |
Note générale : | https://doi.org/10.1016/j.ctcp.2021.101415 |
Langues: | Anglais |
Résumé : |
Background
and purpose. COVID-19 is a novel viral disease causing worldwide pandemia. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to hospitalized patients with confirmed symptomatic SARS-CoV-2 infection. Patient presentation Thirteen patients with COVID-19 were admitted. Mean age was 73.4 ± 15.0 (SD) years. Twelve (92.3%) were speedily discharged without relevant sequelae after 14.4 ± 8.9 days. A single patient admitted in an advanced stage of septic disease died in hospital. A time-dependent improvement of relevant clinical symptoms was observed in the 12 surviving patients. Six (46.2%) were critically ill and treated in the intensive care unit (ICU). Mean stay at the ICU of the 5 surviving patients was 18.8 ± 6.8 days. In six patients (46.2%) gastrointestinal disorders accompanied COVID-19. Conclusion The observations suggest that adjunctive homeopathic treatment may be helpful to treat patients with confirmed COVID-19 even in high risk patients especially since there is no conventional treatment of COVID-19 available at present. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S1744388121001146 |